intravenous anaesthesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1-2 Age 18-65 years Patient undergoing intravenous anaesthesia Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 50 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Contraindications to intravenous anaesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: pharmacokinetics;Secondary Objective: NA;Primary end point(s): Qualitative and quantitative anaylsis UHPLC-MS/MS;Timepoint(s) of evaluation of this end point: before anaesthesia, 3-5 minutes after dosing, 3-5 minutes after start of surgical intervention, next intervals 10-15 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): other pharmacokinetics parameters;Timepoint(s) of evaluation of this end point: NA | — |
Countries
Czech Republic
Contacts
Podripská nemocnice s poliklinikou, Roudnice n.L., s.r.o